Display options
Share it on

Front Med (Lausanne). 2020 Jun 05;7:198. doi: 10.3389/fmed.2020.00198. eCollection 2020.

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma.

Frontiers in medicine

Glenn J Hanna, Alec J Kacew, Anusha R Tanguturi, Hans J Grote, Victoria Vergara, Beatrice Brunkhorst, Guilherme Rabinowits, Manisha Thakuria, Nicole R LeBoeuf, Christian Ihling, James A DeCaprio, Jochen H Lorch

Affiliations

  1. Head and Neck Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
  2. Boston University School of Medicine, Boston, MA, United States.
  3. Merck KGaA, Darmstadt, Germany.
  4. EMD Serono, Research and Development Institute, Billerica, MA, United States.
  5. Hematology/Oncology, Miami Cancer Institute, Miami, FL, United States.
  6. Dermatology, Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, United States.
  7. Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

PMID: 32582722 PMCID: PMC7291775 DOI: 10.3389/fmed.2020.00198

[No abstract available.]

Copyright © 2020 Hanna, Kacew, Tanguturi, Grote, Vergara, Brunkhorst, Rabinowits, Thakuria, LeBoeuf, Ihling, DeCaprio and Lorch.

Keywords: MCPyV; PD-L1; cancer; merkel cell carcinoma; merkel cell polyomavirus; neuroendocrine carcinoma; prognostic biomarkers

References

  1. Oncol Rep. 2003 May-Jun;10(3):577-85 - PubMed
  2. Am J Clin Pathol. 1998 May;109(5):565-70 - PubMed
  3. Cancer. 2017 Apr 15;123(8):1464-1474 - PubMed
  4. Sci Transl Med. 2012 Mar 28;4(127):127ra37 - PubMed
  5. Science. 2008 Feb 22;319(5866):1096-100 - PubMed
  6. Pathology. 2017 Aug;49(5):499-505 - PubMed
  7. Lancet Oncol. 2016 Oct;17(10):1374-1385 - PubMed
  8. JAMA Otolaryngol Head Neck Surg. 2015 Feb;141(2):137-41 - PubMed
  9. Int J Cancer. 2009 Sep 15;125(6):1250-6 - PubMed
  10. J Invest Dermatol. 2013 Jul;133(7):1879-89 - PubMed
  11. N Engl J Med. 2016 Jun 30;374(26):2542-52 - PubMed
  12. Head Neck. 1995 Mar-Apr;17(2):96-101 - PubMed
  13. Semin Diagn Pathol. 2000 May;17(2):162-8 - PubMed
  14. Cancer Res. 2010 Nov 1;70(21):8388-97 - PubMed
  15. Tumori. 2003 Mar-Apr;89(2):146-51 - PubMed
  16. Cancer Immunol Res. 2013 Jul;1(1):54-63 - PubMed
  17. J Virol. 2010 Jul;84(14):7064-72 - PubMed
  18. Cancer Invest. 1991;9(2):129-32 - PubMed
  19. Oncotarget. 2017 Aug 12;8(48):83986-83994 - PubMed
  20. Oncotarget. 2017 May 9;8(19):31347-31354 - PubMed
  21. J Cutan Med Surg. 2000 Oct;4(4):186-95 - PubMed
  22. Cancer Med. 2018 Jan;7(1):32-45 - PubMed
  23. Curr Top Microbiol Immunol. 2011;350:17-37 - PubMed
  24. Pathology. 2001 Feb;33(1):21-5 - PubMed
  25. J Immunother Cancer. 2018 Jan 19;6(1):7 - PubMed
  26. Hum Pathol. 2015 Mar;46(3):443-53 - PubMed
  27. Cancers (Basel). 2014 Jun 27;6(3):1328-50 - PubMed
  28. Arch Otolaryngol Head Neck Surg. 2001 Feb;127(2):149-54 - PubMed
  29. Clin Cancer Res. 2013 Oct 1;19(19):5351-60 - PubMed

Publication Types

Grant support